113. Muscular dystrophy Clinical trials / Disease details


Clinical trials : 622 Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00167609
(ClinicalTrials.gov)
November 200410/9/2005Efficacy and Safety of DHEA for Myotonic DystrophyPhase 3 Study of Oral Dehydroepiandrosterone (DHEA) in Adults With Myotonic DystrophyMyotonic DystrophyDrug: dehydroepiandrosterone 100 and 400 mgUniversity of VersaillesAssociation Française contre les Myopathies (AFM), Paris;AP-HPCompleted18 Years70 YearsBoth75Phase 2/Phase 3France